Organogenesis Holdings Inc
ORGO5.630USD
+1.740+44.73%
Fechamento 11/07, 16:00（ET）Cotações atrasadas em 15 min
714.51MValor de mercado
PerdaP/L TTM
Mais detalhes de Organogenesis Holdings Inc Empresa
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Its advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier and native, cross-linked extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types. Sports Medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for management of open wounds in the surgical setting.
Informações de Organogenesis Holdings Inc
Código da empresaORGO
Nome da EmpresaOrganogenesis Holdings Inc
Data de listagemDec 02, 2016
CEOMr. Gary S. Gillheeney, Sr.
Número de funcionários869
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 02
Endereço85 Dan Rd
CidadeCANTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal02021-2810
Telefone17815750775
Sitehttps://investors.organogenesis.com
Código da empresaORGO
Data de listagemDec 02, 2016
CEOMr. Gary S. Gillheeney, Sr.
Executivos da empresa Organogenesis Holdings Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
12.25M
+2.82%
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
447.51K
-8.12%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
419.71K
+150.65%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
202.42K
+0.94%
Mr. Robert Cavorsi
Mr. Robert Cavorsi
Vice President - Strategy
Vice President - Strategy
189.16K
-0.19%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Mr. Arthur S. Leibowitz, CPA
Mr. Arthur S. Leibowitz, CPA
Lead Independent Director
Lead Independent Director
187.61K
+0.78%
Ms. Prathyusha Duraibabu, CPA
Ms. Prathyusha Duraibabu, CPA
Independent Director
Independent Director
148.64K
+3.64%
Mr. Jon L. Giacomin
Mr. Jon L. Giacomin
Independent Director
Independent Director
142.62K
+2.31%
Dr. Gilberto Quintero, Ph.D.
Dr. Gilberto Quintero, Ph.D.
Independent Director
Independent Director
140.67K
+1.04%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
12.25M
+2.82%
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
447.51K
-8.12%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
419.71K
+150.65%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
202.42K
+0.94%
Mr. Robert Cavorsi
Mr. Robert Cavorsi
Vice President - Strategy
Vice President - Strategy
189.16K
-0.19%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por EmpresaUSD
Nome
Receita
Proporção
Advanced Wound Care
92.70M
91.98%
Surgical & Sports Medicine
8.08M
8.02%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Advanced Wound Care
92.70M
91.98%
Surgical & Sports Medicine
8.08M
8.02%
Distribuição de ações
Atualizado em: ter, 19 de ago
Atualizado em: ter, 19 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Soleus Capital Management, L.P.
9.73%
Nussdorf (Glenn H)
9.65%
Morgan Stanley & Co. LLC
9.44%
Ades (Alan A)
8.82%
Erani (Dennis)
7.91%
Outro
54.45%
Investidores
Investidores
Proporção
Soleus Capital Management, L.P.
9.73%
Nussdorf (Glenn H)
9.65%
Morgan Stanley & Co. LLC
9.44%
Ades (Alan A)
8.82%
Erani (Dennis)
7.91%
Outro
54.45%
Tipos de investidores
Investidores
Proporção
Individual Investor
32.98%
Investment Advisor
18.24%
Investment Advisor/Hedge Fund
15.90%
Corporation
14.12%
Hedge Fund
11.28%
Research Firm
10.23%
Pension Fund
0.57%
Bank and Trust
0.14%
Sovereign Wealth Fund
0.05%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
284
71.59M
56.41%
-2.03M
2025Q2
303
127.55M
100.55%
+5.63M
2025Q1
324
125.21M
99.06%
+1.00M
2024Q4
344
121.01M
95.72%
-4.65M
2024Q3
354
109.09M
82.30%
-7.23M
2024Q2
369
107.79M
81.32%
-6.45M
2024Q1
374
102.47M
77.65%
-12.90M
2023Q4
378
102.14M
77.80%
-10.89M
2023Q3
390
113.75M
86.92%
-11.36M
2023Q2
400
112.98M
86.34%
-14.25M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Soleus Capital Management, L.P.
12.34M
9.73%
-135.00K
-1.08%
Jun 30, 2025
Nussdorf (Glenn H)
11.91M
9.39%
--
--
Jun 24, 2025
Morgan Stanley & Co. LLC
11.98M
9.45%
-50.05K
-0.42%
Jun 30, 2025
Ades (Alan A)
11.19M
8.82%
--
--
Jun 24, 2025
Erani (Dennis)
10.04M
7.92%
--
--
Jun 24, 2025
Organo PFG LLC
8.28M
6.53%
--
--
Jun 24, 2025
RED Holdings, L.L.C.
6.78M
5.35%
--
--
Jun 24, 2025
First Light Asset Management, LLC
6.78M
5.34%
+6.78M
--
Jun 30, 2025
The Vanguard Group, Inc.
5.20M
4.1%
+765.38K
+17.27%
Jun 30, 2025
Assenagon Asset Management S.A.
4.85M
3.83%
+2.00M
+69.88%
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
WisdomTree US SmallCap Fund
0.12%
iShares Micro-Cap ETF
0.06%
Franklin US Small Cap Multifactor Index ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Vanguard US Momentum Factor ETF
0.04%
Fidelity Enhanced Small Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
iShares Morningstar Small-Cap Value ETF
0.01%
Ver Mais
WisdomTree US SmallCap Fund
Proporção0.12%
iShares Micro-Cap ETF
Proporção0.06%
Franklin US Small Cap Multifactor Index ETF
Proporção0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.05%
Vanguard US Momentum Factor ETF
Proporção0.04%
Fidelity Enhanced Small Cap ETF
Proporção0.03%
Avantis US Small Cap Equity ETF
Proporção0.03%
iShares Russell 2000 Growth ETF
Proporção0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0.02%
iShares Morningstar Small-Cap Value ETF
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
